tm logo
MAGLUMI
Live/Registered
SECTION 71 ACCEPTED

on 02 May 2022

Last Applicant/ Owned by

No.23, Jinxiu East Road,

Shenzhen, Guangdong

CN

Serial Number

79139817 filed on 17th Jul 2013

Registration Number

4683169 registered on 10th Feb 2015

in the Principal Register

Correspondent Address

Nazly Aileen Bayramoglu

Nazly Aileen Bayramoglu

1540 West Warm Springs Road, Suite 100

Henderson NV 89014

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

MAGLUMI

Blood testing apparatus; [ massage apparatus; ] apparatus for use in medical analysis, namely, medical analyzer for analysis of blood samples, body fluids and body tissue samples; testing apparatus for medical purposes, namely, medical testing instrument for testing blood samples, body fluids and body tissue samples; diagnostic apparatus for medical purposes, namely, medical diagnostic analyzer fo Read More

Classification Information


Class [010]
Medical Instrument Products


Blood testing apparatus; [ massage apparatus; ] apparatus for use in medical analysis, namely, medical analyzer for analysis of blood samples, body fluids and body tissue samples; testing apparatus for medical purposes, namely, medical testing instrument for testing blood samples, body fluids and body tissue samples; diagnostic apparatus for medical purposes, namely, medical diagnostic analyzer for analyzing blood samples, body fluids and body tissue samples; radiotherapy apparatus; ultrasonic devices and parts thereof for medical use, namely, clinical ultrasonic diagnostic apparatus and parts thereof [ ; artificial limbs; multifunction corsets for medical purpose, namely, diagnosis and therapeutic corsets for medical purpose; suture materials ]

Class [005]
Pharmaceutical Products


Drugs for medical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin disease; medicated serums for invitro diagnosis and treatment; medicated serums for in-vivo diagnosis and treatment; serotherapeutic medicines; cultures of microorganisms for medical and veterinary use; biological preparations for pharmaceutical purposes for treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; chemical preparations for pharmaceutical purposes, namely, for diagnosis or treatment of tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; Diagnostic preparations for medical purposes, namely, for diagnosing or detecting tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, TORCH infections and immunoglobulin diseases; enzymes for medical purposes; enzyme preparations for medical purposes; chemical preparations for the diagnosis of pregnancy

Mark Details


Serial Number

No 79139817

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
10th Feb 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
12th May 2023INTERNATIONAL REGISTRATION RENEWED
12th Apr 2023PARTIAL INVALIDATION PROCESSED BY THE IB
22nd Feb 2023GENERIC MADRID TRANSACTION CREATED
22nd Feb 2023GENERIC MADRID TRANSACTION SENT TO IB
02th Jan 2023PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
02th May 2022REGISTERED-SEC.71 ACCEPTED
02th May 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
19th Nov 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
27th Oct 2021POST REGISTRATION ACTION MAILED - SEC.71